Prenetics旗下的行動基因的ACTOnco® IVD產品獲得FDA許可 成為首家就適用於所有實體腫瘤的癌症基因檢測取得許可的亞洲公司 Prenetics Global Limited Jan 11, 2023 11:20 HKT/SGT Read More
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors Prenetics Global Limited Jan 11, 2023 11:19 HKT/SGT Read More
エーザイ、抗アミロイドβプロトフィブリル抗体「レカネマブ」について、欧州において早期アルツハイマー病に係る適応で販売承認申請を提出 Eisai Jan 11, 2023 09:00 JST Read More
君聖泰HTD1801治療非酒精性脂肪性肝炎(NASH)的臨床IIb 期研究(CENTRICITY研究)完成首例患者給藥 HighTide Therapeutics Inc. Jan 11, 2023 08:01 HKT/SGT Read More
君圣泰HTD1801治疗非酒精性脂肪性肝炎(NASH)的临床IIb 期研究(CENTRICITY研究)完成首例患者给药 HighTide Therapeutics Inc. Jan 11, 2023 08:00 HKT/SGT Read More
China Biotech Services subsidiary AMDL nominated as Top Clinical Laboratory Services Company in APAC 2022 and receives CAP Accreditation Certificate China Biotech Services Holdings Limited Jan 10, 2023 16:33 HKT/SGT Read More
Eisai Submits Supplemental Biologics License Application to FDA for Traditional Approval of LEQEMBI (lecanemab-irmb) for the Treatment of Alzheimer's Disease Eisai Jan 09, 2023 20:55 HKT/SGT Read More
FDA Approves LEQEMBI (lecanemab-irmb) Under the Accelerated Approval Pathway for the Treatment of Alzheimer's Disease Eisai Jan 09, 2023 19:40 HKT/SGT Read More
Malaysian Genomics Explores R&D Collaboration with SIRIM Malaysian Genomics Resource Centre Bhd Jan 09, 2023 14:00 HKT/SGT Read More
HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations HighTide Therapeutics Inc. Jan 05, 2023 18:00 HKT/SGT Read More
君聖泰完成1.07 億美元C/C+輪融資,加速推進在研管線的全球開發、商業化和商務拓展 HighTide Therapeutics Inc. Jan 05, 2023 08:01 HKT/SGT Read More
君圣泰完成1.07 亿美元C/C+轮融资,加速推进在研管线的全球开发、商业化和商务拓展 HighTide Therapeutics Inc. Jan 05, 2023 08:00 HKT/SGT Read More
四环医药(0460.HK):惠升生物成功完成A +轮融资,加速糖尿病及并发症领域布局 Sihuan Pharmaceutical Holdings Group Ltd. Jan 04, 2023 09:57 HKT/SGT Read More
四環醫藥(0460.HK):惠升生物成功完成A +輪融資,加速糖尿病及併發症領域佈局 Sihuan Pharmaceutical Holdings Group Ltd. Jan 04, 2023 09:56 HKT/SGT Read More
Sihuan Pharmaceutical (0460.HK): Huisheng Biopharmaceutical Successfully Completes A+ Round of Financing, Accelerating the Layout of Diabetes and Complications Sihuan Pharmaceutical Holdings Group Ltd. Jan 04, 2023 09:55 HKT/SGT Read More
Beauty Farm Medical and Health Industry Inc. Announces Proposed Listing on the Main Board of SEHK, Offer price at HK$19.32 per share Beauty Farm Medical and Health Industry Inc. Dec 30, 2022 10:18 HKT/SGT Read More